On Monday, ProQR Therapeutics N.V (NASDAQ: PRQR) opened higher 5.15% from the last session, before settling in for the closing price of $2.33. Price fluctuations for PRQR have ranged from $1.07 to $3.27 over the past 52 weeks.
Annual sales at Healthcare sector company grew by 25.70% over the past five years. Company’s average yearly earnings per share was noted -29.45% at the time writing. With a float of $70.02 million, this company’s outstanding shares have now reached $105.35 million.
ProQR Therapeutics N.V (PRQR) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of ProQR Therapeutics N.V is 33.45%, while institutional ownership is 35.10%.
ProQR Therapeutics N.V (PRQR) Latest Financial update
If we go through the results of last quarter, which was made public on 12/31/2024, the company posted -0.1 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -0.15) by 0.05. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.14 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -29.45% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -21.61% during the next five years compared to 25.70% growth over the previous five years of trading.
ProQR Therapeutics N.V (NASDAQ: PRQR) Trading Performance Indicators
Check out the current performance indicators for ProQR Therapeutics N.V (PRQR). In the past quarter, the stock posted a quick ratio of 3.36. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 15.12.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.46, a number that is poised to hit -0.12 in the next quarter and is forecasted to reach -0.62 in one year’s time.
Technical Analysis of ProQR Therapeutics N.V (PRQR)
ProQR Therapeutics N.V (NASDAQ: PRQR) saw its 5-day average volume 0.78 million, a positive change from its year-to-date volume of 0.45 million. As of the previous 9 days, the stock’s Stochastic %D was 88.16%.
During the past 100 days, ProQR Therapeutics N.V’s (PRQR) raw stochastic average was set at 50.00%, which indicates a significant decrease from 95.58% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.19 in the past 14 days, which was higher than the 0.17 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.38, while its 200-day Moving Average is $2.01. Nevertheless, the first resistance level for the watch stands at $2.52 in the near term. At $2.58, the stock is likely to face the second major resistance level. The third major resistance level sits at $2.69. If the price goes on to break the first support level at $2.34, it is likely to go to the next support level at $2.23. The third support level lies at $2.17 if the price breaches the second support level.
ProQR Therapeutics N.V (NASDAQ: PRQR) Key Stats
There are currently 105,213K shares outstanding in the company with a market cap of 257.77 million. Presently, the company’s annual sales total 20,460 K according to its annual income of -30,040 K. Last quarter, the company’s sales amounted to 3,370 K and its income totaled -12,860 K.
